SUPERNUS PHARMACEUTICALS, INC. (SUPN) has 116 open-market insider trades by 25 insiders since 2012. The most active filer is Padmanabh P. Bhatt, CSO & VP.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| M. James Barrett | Dir | — | 7 | $31.6M | 2016-03-16 |
| Scott D. Sandell | 10% | — | 3 | $25.9M | 2015-11-11 |
| Charles W. Newhall III | Dir | — | 3 | $22.5M | 2026-02-24 |
| Jack A. Khattar | CEOPres | — | 15 | $20.9M | 2026-08-12 |
| Padmanabh P. Bhatt | CSOVP | — | 24 | $14.2M | 2026-08-12 |
| Gregory S. Patrick | CFOVP | — | 15 | $12.8M | 2020-11-09 |
| Stefan K.f. Schwabe | PresCMOVP | — | 4 | $9.9M | 2020-12-21 |
| Victor Vaughn | VP | — | 6 | $7.8M | 2018-04-19 |
| Capital Gp Ii Llc Orbimed | 10% | — | 2 | $7.6M | 2012-12-18 |
| Michael B. Sheffery | Dir | — | 1 | $5.5M | 2012-05-04 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Padmanabh P. Bhatt | CSO & VP | Sell | $5.4M | 2026-03-16 |
| Jack A. Khattar | CEO & President | Sell | $1.8M | 2026-03-13 |
| Frederick M. Hudson | Director | Sell | $272K | 2026-03-12 |
| Frank Mottola | VP | Sell | $87K | 2026-03-09 |
| William Todd Horich | VP | Sell | $484K | 2026-03-09 |
| Georges Gemayel | Director | Sell | $1.0M | 2026-03-05 |
Companies that share insiders with SUPN, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Bethany Sensenig | Director | Sell | $228K | 2026-02-19 |
| Frank Mottola | VP | Sell | $1.0M | 2025-12-19 |
| Padmanabh P. Bhatt | CSO & Sr. VP of IP | Sell | $32K | 2025-12-18 |
| Charles W. Newhall III | Director | Sell | $1.3M | 2025-10-09 |
| Jack A. Khattar | CEO & President | Sell | $6.1M | 2025-10-09 |
| Jack A. Khattar | CEO & President | Sell | $183K | 2025-10-02 |
| Jack A. Khattar | CEO & President | Sell | $3.9M | 2025-10-01 |
| Jack A. Khattar | CEO & President | Sell | $414K | 2025-09-30 |
| Jack A. Khattar | CEO & President | Sell | $983K | 2025-09-29 |